IL94847A0 - Control of aberrant expression vector accumulation during fermentation procedures - Google Patents
Control of aberrant expression vector accumulation during fermentation proceduresInfo
- Publication number
- IL94847A0 IL94847A0 IL94847A IL9484790A IL94847A0 IL 94847 A0 IL94847 A0 IL 94847A0 IL 94847 A IL94847 A IL 94847A IL 9484790 A IL9484790 A IL 9484790A IL 94847 A0 IL94847 A0 IL 94847A0
- Authority
- IL
- Israel
- Prior art keywords
- expression vector
- during fermentation
- control
- aberrant expression
- accumulation during
- Prior art date
Links
- 239000013604 expression vector Substances 0.000 title abstract 3
- 230000001594 aberrant effect Effects 0.000 title abstract 2
- 238000009825 accumulation Methods 0.000 title abstract 2
- 238000000855 fermentation Methods 0.000 title abstract 2
- 230000004151 fermentation Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Alcoholic Beverages (AREA)
- Fertilizers (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37157989A | 1989-06-26 | 1989-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL94847A0 true IL94847A0 (en) | 1991-04-15 |
Family
ID=23464539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL94847A IL94847A0 (en) | 1989-06-26 | 1990-06-22 | Control of aberrant expression vector accumulation during fermentation procedures |
Country Status (13)
Country | Link |
---|---|
US (1) | US5824496A (xx) |
EP (1) | EP0405858B1 (xx) |
JP (1) | JPH0347081A (xx) |
AT (1) | ATE125300T1 (xx) |
AU (1) | AU617057B2 (xx) |
CA (1) | CA2019696A1 (xx) |
DE (1) | DE69020968T2 (xx) |
DK (1) | DK0405858T3 (xx) |
ES (1) | ES2076318T3 (xx) |
GR (1) | GR3017703T3 (xx) |
HU (1) | HUT54415A (xx) |
IE (1) | IE67799B1 (xx) |
IL (1) | IL94847A0 (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5395761A (en) * | 1991-11-27 | 1995-03-07 | Eli Lilly And Company | Plasmid pHKY334, an expression vector for EK-BGH and host cells transformed therewith |
US6406855B1 (en) | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55127986A (en) * | 1979-03-26 | 1980-10-03 | Agency Of Ind Science & Technol | Bacteria pretreatment with antibiotic inhibiting synthesis of cell wall |
US4529695A (en) * | 1981-06-18 | 1985-07-16 | Wisconsin Alumni Research Foundation | Recombinant cloning vector, host for the vector, and method for using same |
CA1206433A (en) * | 1982-08-06 | 1986-06-24 | Channing R. Robertson | Production of biological products using resting cells |
EP0178764A1 (en) * | 1984-08-28 | 1986-04-23 | Genex Corporation | Method of stabilizing a host microorganism/expression vector system for large scale production of proteins |
-
1990
- 1990-06-22 AU AU57805/90A patent/AU617057B2/en not_active Ceased
- 1990-06-22 DK DK90306853.4T patent/DK0405858T3/da active
- 1990-06-22 EP EP90306853A patent/EP0405858B1/en not_active Expired - Lifetime
- 1990-06-22 DE DE69020968T patent/DE69020968T2/de not_active Expired - Fee Related
- 1990-06-22 ES ES90306853T patent/ES2076318T3/es not_active Expired - Lifetime
- 1990-06-22 IL IL94847A patent/IL94847A0/xx unknown
- 1990-06-22 AT AT90306853T patent/ATE125300T1/de not_active IP Right Cessation
- 1990-06-22 CA CA002019696A patent/CA2019696A1/en not_active Abandoned
- 1990-06-25 IE IE228990A patent/IE67799B1/en not_active IP Right Cessation
- 1990-06-25 HU HU903975A patent/HUT54415A/hu unknown
- 1990-06-25 JP JP2166529A patent/JPH0347081A/ja active Pending
-
1995
- 1995-08-10 US US08/513,598 patent/US5824496A/en not_active Expired - Fee Related
- 1995-10-11 GR GR950402812T patent/GR3017703T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0347081A (ja) | 1991-02-28 |
DK0405858T3 (da) | 1995-09-04 |
HUT54415A (en) | 1991-02-28 |
IE902289A1 (en) | 1991-01-16 |
ES2076318T3 (es) | 1995-11-01 |
IE67799B1 (en) | 1996-05-01 |
CA2019696A1 (en) | 1990-12-26 |
HU903975D0 (en) | 1990-11-28 |
AU5780590A (en) | 1991-01-03 |
DE69020968D1 (de) | 1995-08-24 |
AU617057B2 (en) | 1991-11-14 |
US5824496A (en) | 1998-10-20 |
GR3017703T3 (en) | 1996-01-31 |
IE902289L (en) | 1990-12-26 |
ATE125300T1 (de) | 1995-08-15 |
EP0405858A2 (en) | 1991-01-02 |
DE69020968T2 (de) | 1995-12-21 |
EP0405858B1 (en) | 1995-07-19 |
EP0405858A3 (en) | 1992-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3032790T3 (en) | Materials and methods for hypersecretion of amino acids | |
IL142269A (en) | Process for recovering heterologous polypeptides from bacterial cells | |
HK1013427A1 (en) | Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods | |
ZA872298B (en) | A process for recovery of glycopeptidic antibiotics | |
GR3027671T3 (en) | Protein with bone formation ability and process for its production | |
AU7505796A (en) | Hyperthermostable protease gene | |
DE69739013D1 (de) | Verfahren zur Herstellung sekretorischer KEX2-Derivate | |
SG44824A1 (en) | Process for the hydroformylation of 1,3-butadiene | |
GR3017703T3 (en) | Control of aberrant expression vector accumulation during fermentation procedures. | |
EP0364275A3 (en) | D-amino acid oxidase | |
AU4608689A (en) | Process for the conjugative transfer of mobilizable vectors from e. coli into gram-positive bacteria and vectors which are suitable for this | |
WO1994006918A3 (en) | Transformation of phaffia rhodozyma | |
EP0331635A3 (en) | Preparations for treating bladder cancer | |
IE883850L (en) | Improved vancomycin precipitation process | |
EP0911415A3 (en) | Microbiological manufacture of L-ascorbic acid | |
AU5971090A (en) | Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same | |
PL232798A1 (en) | Process for preparing vector of dna containing the sequence coding somatostatin or precursor of somatostatin | |
GR3030321T3 (en) | Method for casein finishing of leather. | |
EP0638515A3 (de) | Verfahren zur Aufarbeitung von Dünnsäure. | |
AU6042198A (en) | Lage-1 tumor associated nucleic acids | |
ZA936507B (en) | Process for the production of protease inhibitors | |
WO2001053456A8 (en) | Methods and materials relating to prothrombinase-like polypeptides and polynucleotides | |
AU5179596A (en) | Method and means for the production of gene products, novel recombinant dna vectors therefor and kits employing them | |
EP0708180A3 (de) | Verbessertes, induktionsfreies Verfahren zur Gentechnischen Herstellung von Glutarylamidase | |
HU9200745D0 (en) | Process for the production of 2,2-dimethyl-2,3-dihydro-benzofurane-7-carbonic acid derivatives |